C-met modulators and method of use
CA 2537812 C · Owner: Jammalamadaka, Vasu · Inventors: Wang, Yong; Mann, Grace; Khoury, Richard George
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The present invention provides compounds for modulating protein kinase enzymatic activity for modulating cellular activities such as proliferation differentiation, programmed cell death migration and chemoinvasion. More , specifically the invention provides quinazolines and quinolines which inhibit, regulate and/or modulate kinase receptor particularly c-Met, KDR, c-, Kit, flt-3 and flt-4 signal transduction pathways related to the changes in cellular activities as mentioned above compositions which contain these , compounds and methods of using them to treat kinase-dependent diseases and conditions. The present invention also provides methods for making compounds as mentioned above, …
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed September 24, 2004 and granted January 22, 2013. A Canadian patent filed from October 1, 1989 lasts 20 years from filing, so its term ended September 24, 2024.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by September 24, 2026.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.